SE431937B - Salicylazosulfapyridinhaltigt medicinskt preparat - Google Patents

Salicylazosulfapyridinhaltigt medicinskt preparat

Info

Publication number
SE431937B
SE431937B SE7900738A SE7900738A SE431937B SE 431937 B SE431937 B SE 431937B SE 7900738 A SE7900738 A SE 7900738A SE 7900738 A SE7900738 A SE 7900738A SE 431937 B SE431937 B SE 431937B
Authority
SE
Sweden
Prior art keywords
polymer
crosslinked
composition according
groups
salicylazosulfapyridine
Prior art date
Application number
SE7900738A
Other languages
English (en)
Swedish (sv)
Other versions
SE7900738L (sv
Inventor
J A O Johansson
Original Assignee
Perstorp Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Perstorp Ab filed Critical Perstorp Ab
Priority to SE7900738A priority Critical patent/SE431937B/sv
Priority to GB8001484A priority patent/GB2041958B/en
Priority to DE19803003107 priority patent/DE3003107A1/de
Publication of SE7900738L publication Critical patent/SE7900738L/
Publication of SE431937B publication Critical patent/SE431937B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE7900738A 1979-01-29 1979-01-29 Salicylazosulfapyridinhaltigt medicinskt preparat SE431937B (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE7900738A SE431937B (sv) 1979-01-29 1979-01-29 Salicylazosulfapyridinhaltigt medicinskt preparat
GB8001484A GB2041958B (en) 1979-01-29 1980-01-16 Medical preparations containing salicylazosulpha pyridine
DE19803003107 DE3003107A1 (de) 1979-01-29 1980-01-29 Salicylazosulfapyridin-enthaltendes arzneimittel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7900738A SE431937B (sv) 1979-01-29 1979-01-29 Salicylazosulfapyridinhaltigt medicinskt preparat

Publications (2)

Publication Number Publication Date
SE7900738L SE7900738L (sv) 1980-07-30
SE431937B true SE431937B (sv) 1984-03-12

Family

ID=20337130

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7900738A SE431937B (sv) 1979-01-29 1979-01-29 Salicylazosulfapyridinhaltigt medicinskt preparat

Country Status (3)

Country Link
DE (1) DE3003107A1 (de)
GB (1) GB2041958B (de)
SE (1) SE431937B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988006893A1 (en) * 1987-03-13 1988-09-22 Benzon Pharma A/S An oral composition containing particles comprising an active substance

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1131833B (it) * 1980-06-20 1986-06-25 Crinos Industria Farmaco Eccipienti per sostanze spermicide
US5288500A (en) * 1987-03-13 1994-02-22 Benzon Pharma A/S Oral composition containing particles comprising an active substance
DK110188D0 (da) * 1988-03-02 1988-03-02 Claus Selch Larsen High molecular weight prodrug derivatives of antiinflammatory drugs
CN104130186A (zh) * 2014-06-30 2014-11-05 江苏瑞克医药科技有限公司 一种提高柳氮磺吡啶精制生产效率的方法
CN105348184B (zh) * 2015-11-26 2020-12-29 苏州统华药品有限公司 一种柳氮磺吡啶的制备方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988006893A1 (en) * 1987-03-13 1988-09-22 Benzon Pharma A/S An oral composition containing particles comprising an active substance

Also Published As

Publication number Publication date
DE3003107A1 (de) 1980-08-07
GB2041958A (en) 1980-09-17
GB2041958B (en) 1982-11-24
SE7900738L (sv) 1980-07-30

Similar Documents

Publication Publication Date Title
US3275576A (en) Cation-exchangers from cross-linked polyhydroxy materials
US4069306A (en) X-ray contrast preparation containing a hydrophilic polymer containing amino groups
Farhadnejad et al. Facile preparation and characterization of pH sensitive Mt/CMC nanocomposite hydrogel beads for propranolol controlled release
US4175183A (en) Hydroxyalkylated cross-linked regenerated cellulose and method of preparation thereof
FI82682B (fi) Foerfarande foer framstaellning av ett anti-inflammatoriskt och analgetiskt verksamt resinat av en substituerad karboxylsyra.
EP0323627A2 (de) Modifizierte Galaktomannane und Verfahren zu ihrer Herstellung
GB1573513A (en) Hydroxyalkylated cross-linked regenerated cellulose and method of preparation thereof
JPS6317904A (ja) 多孔質架橋ポリビニルアルコ−ル粒子の製造法
EP0324177A1 (de) Trennungsmittelzusammensetzung
EP0375126A1 (de) Verfahren zur Derivatisierung des Polygalaktomannans mit Verwendung der wasserlöslichen Salze von Aluminium in dem Verfahren
SE431937B (sv) Salicylazosulfapyridinhaltigt medicinskt preparat
JP3468594B2 (ja) イヌリン誘導体、その製造方法及びその使用
EP0176225B1 (de) Poröser und geformter Gegenstand auf Basis von Chitin und seine Herstellung
US3979286A (en) Removal of heavy metal ions from aqueous solutions with insoluble cross-linked-starch-xanthates
DE2813921C2 (de) Verfahren zur Herstellung von ionischen Pullulangelen sowie deren Verwendung als Molekularsiebe zur Trennung und Reinigung
EP0312242B1 (de) Ionenaustauscher aus Basis von vernetztem Glukomannan
US3634394A (en) Method for the preparation of novel ion exchangers on the basis of cellulose
JPS6176504A (ja) 粒状多孔質キトサンの製造法
AU636800B2 (en) Galactomannan derivatives for coating or embedding medicinally active substances
JPS61252201A (ja) セルロ−スエ−テルの精製方法
NO873184L (no) Polymer behandlede jone bytte harpiks.
SK116393A3 (en) Oral medicamentous form
US5734031A (en) Cation exchange resin
CN110981984A (zh) 一种高粘度羧甲基淀粉钠的制备方法
JP3994210B2 (ja) イオン交換樹脂の精製法

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7900738-1

Effective date: 19870228